This study demonstrates that β-arrestin-2 in PAR-1-biased signaling plays a pivotal role in stroke or HFD-induced obesity by the enhancement of endothelial function and integrity via PDGF-β. Here, PDGFB is linked to obesity due to melanocortin 4 receptor deficiency.